Evaluating the use of a sustained-release intracanalicular dexamethasone insert (Dextenza, Ocular Therapeutix, Inc) in Minimally invasive glaucoma surgery (MIGS)
Research Grant
Administered By
Ophthalmology, Glaucoma
Awarded By
Ocular Therapeutix Inc
Start Date
April 14, 2021
End Date
March 14, 2026
Administered By
Ophthalmology, Glaucoma
Awarded By
Ocular Therapeutix Inc
Start Date
April 14, 2021
End Date
March 14, 2026